- Ethereum dominance has collapsed to a five-year low of 8%.
- AMBCrypto’s data shows Ethereum’s dominance has declined since mid-2024, despite a bullish cycle.
Ethereum [ETH] emerged as one of Q1’s biggest high-cap underperformers.
While its price drawdown remains in focus, a more concerning metric is its market dominance, which has plunged to a five-year low of 8%.
In fact, it’s the metric that has retracted levels last witnessed during the COVID-induced market cycle.
Back then, ETH dominance staged a sharp Q2 recovery, reclaiming a double-digit foothold.
However, this time, key technicals diverge – RSI remains anchored in oversold territory, failing to reset despite ETH trading at a two-year low.
Source: TradingView (ETH.D)
Clearly, Ethereum’s risk-off sentiment remains elevated, suppressing fresh retail inflows and limiting upside momentum. Given the current conditions, a 2020-style dominance resurgence appears unlikely.
Additionally, beyond on-chain metrics and technicals, a broader structural shift is evident.
AMBCrypto’s analysis of the chart above highlights Ethereum’s sustained dominance downtrend since mid-2024, despite a historically bullish macrocycle.
Key catalysts – including post-halving capital rotations, the Trump rally, and the Federal Reserve’s three rate cuts – failed to ignite a meaningful recovery.
Despite these tailwinds, ETH closed the year with a modest 47% annual gain.
However, its market dominance eroded by 4%, retracing to 12% by Q4 2024, underscoring persistent “relative” weakness against broader market trends.
Ethereum dominance declines against macro trends
As Ethereum’s dominance eroded throughout 2024, Bitcoin’s market dominance (BTC.D) surged from 54% to 61% by mid-Q4, propelling BTC’s total market capitalization near the $2 trillion milestone for the first time in history.
Source: CoinMarketCap
This shift underscores ETH’s relative weakness, driven by aggressive capital rotations into Bitcoin, fueled by macro-driven risk positioning and speculative front-running of a potential “Trump pump.”
A similar capital flow imbalance is now unfolding. Institutional demand for Bitcoin has dominated since March, while ETH ETFs continue to bleed outflows, signaling weak conviction.
As macro uncertainty deepens, institutional liquidity will dictate market stability. Bitcoin is increasingly cementing its role as a risk-off asset.
Meanwhile, Ethereum continues to lose market share – its five-year dominance low reinforcing the narrative of persistent capital rotation away from ETH.
- Ethereum dominance has collapsed to a five-year low of 8%.
- AMBCrypto’s data shows Ethereum’s dominance has declined since mid-2024, despite a bullish cycle.
Ethereum [ETH] emerged as one of Q1’s biggest high-cap underperformers.
While its price drawdown remains in focus, a more concerning metric is its market dominance, which has plunged to a five-year low of 8%.
In fact, it’s the metric that has retracted levels last witnessed during the COVID-induced market cycle.
Back then, ETH dominance staged a sharp Q2 recovery, reclaiming a double-digit foothold.
However, this time, key technicals diverge – RSI remains anchored in oversold territory, failing to reset despite ETH trading at a two-year low.
Source: TradingView (ETH.D)
Clearly, Ethereum’s risk-off sentiment remains elevated, suppressing fresh retail inflows and limiting upside momentum. Given the current conditions, a 2020-style dominance resurgence appears unlikely.
Additionally, beyond on-chain metrics and technicals, a broader structural shift is evident.
AMBCrypto’s analysis of the chart above highlights Ethereum’s sustained dominance downtrend since mid-2024, despite a historically bullish macrocycle.
Key catalysts – including post-halving capital rotations, the Trump rally, and the Federal Reserve’s three rate cuts – failed to ignite a meaningful recovery.
Despite these tailwinds, ETH closed the year with a modest 47% annual gain.
However, its market dominance eroded by 4%, retracing to 12% by Q4 2024, underscoring persistent “relative” weakness against broader market trends.
Ethereum dominance declines against macro trends
As Ethereum’s dominance eroded throughout 2024, Bitcoin’s market dominance (BTC.D) surged from 54% to 61% by mid-Q4, propelling BTC’s total market capitalization near the $2 trillion milestone for the first time in history.
Source: CoinMarketCap
This shift underscores ETH’s relative weakness, driven by aggressive capital rotations into Bitcoin, fueled by macro-driven risk positioning and speculative front-running of a potential “Trump pump.”
A similar capital flow imbalance is now unfolding. Institutional demand for Bitcoin has dominated since March, while ETH ETFs continue to bleed outflows, signaling weak conviction.
As macro uncertainty deepens, institutional liquidity will dictate market stability. Bitcoin is increasingly cementing its role as a risk-off asset.
Meanwhile, Ethereum continues to lose market share – its five-year dominance low reinforcing the narrative of persistent capital rotation away from ETH.
clomid other name can i order clomid online how to get clomiphene no prescription can you buy cheap clomiphene without insurance cost cheap clomid without rx where to buy generic clomid price clomiphene sale
Thanks on putting this up. It’s evidently done.
The thoroughness in this piece is noteworthy.
generic azithromycin 250mg – buy sumycin 500mg sale purchase metronidazole sale
where to buy motilium without a prescription – buy generic domperidone flexeril uk
buy azithromycin 500mg pill – buy bystolic 5mg generic brand bystolic
augmentin buy online – atbioinfo.com buy ampicillin generic
purchase esomeprazole – anexa mate order esomeprazole 20mg generic
how to get coumadin without a prescription – cou mamide purchase hyzaar pill
buy meloxicam cheap – https://moboxsin.com/ order meloxicam 7.5mg for sale
order generic prednisone – https://apreplson.com/ prednisone 10mg without prescription
buy ed pills gb – medicine erectile dysfunction cheap ed pills
buy amoxicillin medication – combamoxi.com order amoxicillin online
purchase forcan generic – diflucan order buy fluconazole
buy escitalopram 10mg online – https://escitapro.com/ buy escitalopram 20mg
buy cheap generic cenforce – https://cenforcers.com/ cenforce 50mg pill
pictures of cialis – san antonio cialis doctor cialis windsor canada
cialis manufacturer coupon 2018 – cialis at canadian pharmacy buy cialis online without prescription
order zantac pills – click buy zantac generic
viagra online generic cheap – on this site generic viagra cheap shipping
This is a topic which is virtually to my callousness… Numberless thanks! Quite where can I upon the contact details for questions? https://buyfastonl.com/furosemide.html
I couldn’t turn down commenting. Adequately written! https://gnolvade.com/
More posts like this would add up to the online play more useful. https://ursxdol.com/cialis-tadalafil-20/
This is the description of glad I get high on reading. https://prohnrg.com/
This is the type of post I find helpful. lasix contre indication